Labeler
Allergan, Inc. NDC Codes
Allergan, Inc. lists 134 finished drug products in the FDA NDC Directory under NDC labeler codes 0023, 0430, 0456, 57970, 58914, 61874.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Vraylar, Fetzima, Savella, Namzaric, Bystolic, REFRESH Optive Mega-3, Linzess, Saphris, Viibryd, Lexapro, Lastacaft, Refresh RELIEVA PF, Ubrelvy, Viberzi, REFRESH OPTIVE Advanced
- Active ingredients
- Carboxymethylcellulose sodium, Glycerin, Polysorbate 80, Cariprazine, Zinc oxide, Memantine hydrochloride, Donepezil hydrochloride, Levomilnacipran hydrochloride, Milnacipran hydrochloride, Nebivolol hydrochloride, Bimatoprost, Linaclotide
- NDC labeler codes
- 0023, 0430, 0456, 57970, 58914, 61874
- Strengths (from the 100 most recently listed products)
- Carboxymethylcellulose sodium 5 mg/mL; Glycerin 10 mg/mL; Polysorbate 80 5 mg/mL; Glycerin 9 mg/mL; Donepezil hydrochloride 10 mg/1; Octinoxate 75 mg/g; Salicylic acid 20 mg/mL; Alcaftadine 2.5 mg/mL; Cyclosporine .5 mg/mL; Titanium dioxide 50 mg/g; Zinc oxide 60 mg/g; Oxybutynin 3.9 mg/d; Octisalate 30 mg/g; Zinc oxide 80 mg/g; Risedronate sodium hemipentahydrate 30.1 mg/1; Risedronate sodium monohydrate 4.9 mg/1; Cariprazine .5 mg/1; Cariprazine .75 mg/1; Arnica montana 50 [hp_X]/1; Ledum palustre twig 50 [hp_X]/1
- Dosage forms
- Solution/ drops, Tablet, Tablet, Film coated, Capsule, Gelatin coated, Lotion, Kit, Capsule, Capsule, Extended release, Patch, Powder, For solution, Injection, Powder, Lyophilized, For solution, Implant, Emulsion, Ointment, Intrauterine device, Injection, Powder, For solution, Liquid, Tablet, Delayed release, Gel, Cream
- Routes
- Oral, Ophthalmic, Topical, Intravenous, Sublingual, Intramuscular, Transdermal, Intracameral, Intrauterine, Rectal, Intradermal, Intravitreal, Vaginal
- Drug classes (FDA established)
- Non-Standardized Chemical Allergen, Atypical Antipsychotic, Serotonin and Norepinephrine Reuptake Inhibitor, Bisphosphonate, beta-Adrenergic Blocker, Cholinesterase Inhibitor, N-methyl-D-aspartate Receptor Antagonist, Prostaglandin Analog, Guanylate Cyclase-C Agonist, Cephalosporin Antibacterial, Acetylcholine Release Inhibitor, Neuromuscular Blocker, alpha-Adrenergic Agonist, Serotonin Reuptake Inhibitor, Histamine-1 Receptor Antagonist, Calcitonin Gene-related Peptide Receptor Antagonist, Calcineurin Inhibitor Immunosuppressant, Cholinergic Muscarinic Antagonist, mu-Opioid Receptor Agonist, Cyclooxygenase Inhibitor, Nonsteroidal Anti-inflammatory Drug, Progestin, Progestin-containing Intrauterine System, beta Lactamase Inhibitor, Lipoglycopeptide Antibacterial, Nitrate Vasodilator, Quinolone Antimicrobial, Corticosteroid, Estrogen
- HCPCS / J-code
- J0585 — Injection, onabotulinumtoxinA, 1 unit
- Package NDCs
- 198 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Fetzimalevomilnacipran hydrochloride | Levomilnacipran hydrochloride 120 mg/1 | Capsule, Extended releaseOral | 0456-2212 | 00456-2212-3000456-2212-90 | — |
| Fetzimalevomilnacipran hydrochloride | Levomilnacipran hydrochloride 20 mg/1 | Capsule, Extended releaseOral | 0456-2220 | 00456-2220-0700456-2220-30 | — |
| Fetzimalevomilnacipran hydrochloride | Levomilnacipran hydrochloride 40 mg/1 | Capsule, Extended releaseOral | 0456-2240 | 00456-2240-3000456-2240-90 | — |
| Fetzimalevomilnacipran hydrochloride | Levomilnacipran hydrochloride 80 mg/1 | Capsule, Extended releaseOral | 0456-2280 | 00456-2280-3000456-2280-90 | — |
| REFRESH OPTIVE Advancedcarboxymethylcellulose sodium, glycerin, polysorbate 80 | Carboxymethylcellulose sodium 5 mg/mL + 2 more ingredients | Solution/ dropsOphthalmic | 0023-4491 | 00023-4491-0500023-4491-30 | — |
| SKIN MEDICA Purifying Foaming Washsalicylic acid | Salicylic acid 20 mg/mL | LiquidTopical | 0023-4948 | 00023-4948-05 | — |
| Linzesslinaclotide | Linaclotide 145 ug/1 | Capsule, Gelatin coatedOral | 0456-1201 | 00456-1201-0400456-1201-0700456-1201-30 | — |
| Linzesslinaclotide | Linaclotide 290 ug/1 | Capsule, Gelatin coatedOral | 0456-1202 | 00456-1202-0400456-1202-0700456-1202-30 | — |
| REFRESH OPTIVE Advancedcarboxymethylcellulose sodium, glycerin, and polysorbate 80 | Carboxymethylcellulose sodium 5 mg/mL + 2 more ingredients | Solution/ dropsOphthalmic | 0023-4307 | 00023-4307-0200023-4307-1000023-4307-20 | — |
| Rectivnitroglycerin | Nitroglycerin 4 mg/g | OintmentRectal | 58914-301 | 58914-0301-80 | — |
| Viibrydvilazodone hydrochloride | Vilazodone hydrochloride 10 mg/1 | TabletOral | 0456-1110 | 00456-1110-30 | — |
| Viibrydvilazodone hydrochloride | Vilazodone hydrochloride 20 mg/1 | TabletOral | 0456-1120 | 00456-1120-30 | — |
| Viibrydvilazodone hydrochloride | Vilazodone hydrochloride 40 mg/1 | TabletOral | 0456-1140 | 00456-1140-30 | — |
| Lo Loestrin Fenorethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate | — | Kit | 0430-0420 | 00430-0420-1400430-0420-6000430-0420-95 | — |
| Atelviarisedronate sodium | Risedronate sodium hemipentahydrate 30.1 mg/1; Risedronate sodium monohydrate 4.9 mg/1 | Tablet, Delayed releaseOral | 0430-0979 | 00430-0979-03 | — |
| Lastacaftalcaftadine | Alcaftadine 2.5 mg/mL | Solution/ dropsOphthalmic | 0023-4290 | 00023-4290-01 | — |
| Teflaroceftaroline fosamil | Ceftaroline fosamil 600 mg/20mL | Powder, For solutionIntravenous | 0456-0600 | 00456-0600-10 | — |
| Teflaroceftaroline fosamil | Ceftaroline fosamil 400 mg/20mL | Powder, For solutionIntravenous | 0456-0400 | 00456-0400-10 | — |
| Lumiganbimatoprost | Bimatoprost .1 mg/mL | Solution/ dropsOphthalmic | 0023-3205 | 00023-3205-0200023-3205-0300023-3205-05+1 more | — |
| Zymaxidgatifloxacin | Gatifloxacin 5 mg/mL | Solution/ dropsOphthalmic | 0023-3615 | 00023-3615-0100023-3615-25 | — |
| Botoxonabotulinumtoxina | Botulinum toxin type a 200 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntradermal, Intramuscular | 0023-3921 | 00023-3921-0200023-3921-03 | J0585 |
| Ozurdexdexamethasone | Dexamethasone .7 mg/1 | ImplantIntravitreal | 0023-3348 | 00023-3348-0700023-3348-08 | — |
| Acuvailketorolac tromethamine | Ketorolac tromethamine 4.5 mg/mL | Solution/ dropsOphthalmic | 0023-3507 | 00023-3507-0500023-3507-31 | — |
| Savellamilnacipran hydrochloride | — | KitOral | 0456-1500 | 00456-1500-55 | — |
| Savellamilnacipran hydrochloride | Milnacipran hydrochloride 100 mg/1 | Tablet, Film coatedOral | 0456-1510 | 00456-1510-60 | — |
| Savellamilnacipran hydrochloride | Milnacipran hydrochloride 12.5 mg/1 | Tablet, Film coatedOral | 0456-1512 | 00456-1512-60 | — |
| Savellamilnacipran hydrochloride | Milnacipran hydrochloride 25 mg/1 | Tablet, Film coatedOral | 0456-1525 | 00456-1525-60 | — |
| Savellamilnacipran hydrochloride | Milnacipran hydrochloride 50 mg/1 | Tablet, Film coatedOral | 0456-1550 | 00456-1550-60 | — |
| Latissebimatoprost | Bimatoprost .3 mg/mL | Solution/ dropsOphthalmic | 0023-3616 | 00023-3616-0500023-3616-7000023-3616-71 | — |
| Refresh Optivecarboxymethylcellulose sodium, glycerin | Carboxymethylcellulose sodium 5 mg/mL; Glycerin 9 mg/mL | Solution/ dropsOphthalmic | 0023-3416 | 00023-3416-0500023-3416-3000023-3416-60 | — |
| BOTOX Cosmeticonabotulinumtoxina | Botulinum toxin type a 50 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular | 0023-3919 | 00023-3919-5000023-3919-51 | J0585 |
| BOTOX Cosmeticonabotulinumtoxina | Botulinum toxin type a 100 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular | 0023-9232 | 00023-9232-0100023-9232-02 | J0585 |
| Actonelrisedronate sodium | Risedronate sodium hemipentahydrate 129 mg/1; Risedronate sodium monohydrate 21 mg/1 | Tablet, Film coatedOral | 0430-0478 | 00430-0478-01 | — |
| Bystolicnebivolol hydrochloride | Nebivolol hydrochloride 2.5 mg/1 | TabletOral | 0456-1402 | 00456-1402-0100456-1402-3000456-1402-90 | — |
| Bystolicnebivolol hydrochloride | Nebivolol hydrochloride 5 mg/1 | TabletOral | 0456-1405 | 00456-1405-0100456-1405-3000456-1405-90 | — |
| Bystolicnebivolol hydrochloride | Nebivolol hydrochloride 10 mg/1 | TabletOral | 0456-1410 | 00456-1410-0100456-1410-3000456-1410-63+1 more | — |
| Bystolicnebivolol hydrochloride | Nebivolol hydrochloride 20 mg/1 | TabletOral | 0456-1420 | 00456-1420-0100456-1420-6300456-1420-90 | — |
| Combiganbrimonidine tartrate, timolol maleate | Brimonidine tartrate 2 mg/mL; Timolol maleate 5 mg/mL | Solution/ dropsOphthalmic | 0023-9211 | 00023-9211-0300023-9211-0500023-9211-10+1 more | — |
| Refresh Optivecarboxymethylcellulose sodium and glycerin | Carboxymethylcellulose sodium 5 mg/mL; Glycerin 9 mg/mL | Solution/ dropsOphthalmic | 0023-3240 | 00023-3240-15 | — |
| Alphagan Pbrimonidine tartrate | Brimonidine tartrate 1 mg/mL | Solution/ dropsOphthalmic | 0023-9321 | 00023-9321-0300023-9321-0500023-9321-10+1 more | — |
| Acular Lsketorolac tromethamine | Ketorolac tromethamine 4 mg/mL | Solution/ dropsOphthalmic | 0023-9277 | 00023-9277-05 | — |
| Restasiscyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | 0023-9163 | 00023-9163-1200023-9163-3000023-9163-60 | — |
| Oxytroloxybutynin | Oxybutynin 3.9 mg/d | PatchTransdermal | 0023-6153 | 00023-6153-08 | — |
| Lexaproescitalopram | Escitalopram oxalate 10 mg/1 | Tablet, Film coatedOral | 0456-2010 | 00456-2010-01 | — |
| Lexaproescitalopram | Escitalopram oxalate 20 mg/1 | Tablet, Film coatedOral | 0456-2020 | 00456-2020-01 | — |
| Lexaproescitalopram | Escitalopram oxalate 5 mg/1 | Tablet, Film coatedOral | 0456-2005 | 00456-2005-01 | — |
| Actonelrisedronate sodium | Risedronate sodium hemipentahydrate 30.1 mg/1; Risedronate sodium monohydrate 4.9 mg/1 | Tablet, Film coatedOral | 0430-0472 | 00430-0472-03 | — |
| Refresh Liquigelcarboxymethylcellulose sodium | Carboxymethylcellulose sodium, Unspecified 10 mg/mL | GelOphthalmic | 0023-9205 | 00023-9205-15 | — |
| Alphagan Pbrimonidine tartrate | Brimonidine tartrate 1.5 mg/mL | Solution/ dropsOphthalmic | 0023-9177 | 00023-9177-0500023-9177-1000023-9177-15 | — |
| Estraceestradiol | Estradiol .1 mg/g | CreamVaginal | 0430-3754 | 00430-3754-14 | — |
Allergan, Inc.: common questions
- What is Allergan, Inc.'s NDC labeler code?
- 0023, 0430, 0456, 57970, 58914, 61874. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Allergan, Inc.?
- Med-Code's HCPCS directory matches J0585 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.